top of page
NKGen-Biotech.jpeg

Receives FDA Clearance of IND for SNK01 NK Cell Therapy to Treat Moderate Alzheimer's Disease

Access, Ideas, Clarity

A leading virtual platform providing investors with direct access to innovative companies, management teams and thought leaders

Contat Us
bottom of page